KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Treasury Shares (2016 - 2025)

Eli Lilly (LLY) has disclosed Treasury Shares for 17 consecutive years, with $3.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $3.0 billion, compared with a TTM value of $3.0 billion through Dec 2025, changed 0.0%, and an annual FY2025 reading of $3.0 billion, changed 0.0% over the prior year.
  • Treasury Shares was $50.0 million for Q4 2025 at Eli Lilly, up from $3.3 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $50.0 million in Q4 2024 and bottomed at $365000.0 in Q1 2024.
  • Average Treasury Shares over 5 years is $5.5 million, with a median of $450000.0 recorded in 2022.
  • The sharpest move saw Treasury Shares crashed 98.91% in 2024, then skyrocketed 9114.68% in 2025.
  • Year by year, Treasury Shares stood at $52.7 million in 2021, then dropped by 4.17% to $50.5 million in 2022, then fell by 12.48% to $44.2 million in 2023, then soared by 6716.74% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025.
  • Business Quant data shows Treasury Shares for LLY at $3.0 billion in Q4 2025, $62.5 million in Q3 2025, and $3.0 billion in Q2 2025.